European Citizens Launch Initiative to Promote Psychedelic-Assisted Therapies

LOS ANGELES- A coalition of healthcare professionals, academics, and advocates has initiated the PsychedeliCare European Citizens’ Initiative (ECI), aiming to enhance access to psychedelic-assisted therapies across the European Union. The campaign seeks to collect one million signatures from at least seven EU member states by January 2026, compelling the European Commission to consider legislative action.

The initiative’s objectives include establishing standardized guidelines for the safe use of psychedelics in therapeutic settings, increasing EU funding for research into psychedelic therapies, and adopting a unified stance on the legal classification of psychedelics at the international level. Proponents argue that these measures could address the stagnation in psychiatric treatment innovation and provide effective solutions for mental health conditions affecting over 1 in 6 individuals in the EU.

As of January 2025, the petition has garnered over 11,000 signatures. If successful, the European Commission will be obligated to consider the proposed actions, potentially leading to significant advancements in mental health care within the EU.

This initiative reflects a growing recognition of the potential benefits of psychedelic-assisted therapies and represents a concerted effort to integrate them into mainstream medical practice in Europe.